Read on Twitter
$BNGO Megathread.
COVID plays are hot right now and I wanted to find a company offering some kind of help in the pandemic whilst also maintaining a broad scope in which their products can be used. BNGO is this. As always, I'll keep it simple and to the point. Enjoy :))
COVID plays are hot right now and I wanted to find a company offering some kind of help in the pandemic whilst also maintaining a broad scope in which their products can be used. BNGO is this. As always, I'll keep it simple and to the point. Enjoy :))
- $BNGO is the symbol for BioNano Genomics Inc. It trades on the NASDAQ. For ease, I'll refer to BioNano Genomics as $BNGO in this DD.
-They specialize in the research and understanding of genomes.
-Genomes consist of DNA - essentially our genetic makeup. Bear this in mind.
-They specialize in the research and understanding of genomes.
-Genomes consist of DNA - essentially our genetic makeup. Bear this in mind.
-BNGO's main areas of focus atm are cancer, genetic diseases and genome assembly. They also hold a footing against COVID-19 (we'll delve into this later).
-Saphyr is one of their products. Imo this is the key to BNGO. It detects structural variations in genomic DNA.
-Saphyr is one of their products. Imo this is the key to BNGO. It detects structural variations in genomic DNA.
Promising start! Saphyr can basically allow us to compare the intricacies of DNA. This can have so many applications in the fields of science and medicine.
Before we delve into Saphyr's uses against Covid, cancers and more, let's first look at $BNGO's leadership...
Before we delve into Saphyr's uses against Covid, cancers and more, let's first look at $BNGO's leadership...
CEO = Eric Holmlin PhD:
-2 decades of experience in the health sector
-Experience = Genvault Coorp (CEO). Exicon (CCO). Becton Dickinson (VP of Marketing & Development)
-2001 Eric formed GeneOhm Sciences Inc. Orchestrated their acquisition by Becton Dickinson 2006.
-2 decades of experience in the health sector
-Experience = Genvault Coorp (CEO). Exicon (CCO). Becton Dickinson (VP of Marketing & Development)
-2001 Eric formed GeneOhm Sciences Inc. Orchestrated their acquisition by Becton Dickinson 2006.
-Fellow @ Harvard. PhD in Chem from CalTech.
COMPETENCE. This guy seems the real deal. His tech is outstanding, his record speaks for itself, he is highly educated...
GREEN FLAGS.
COMPETENCE. This guy seems the real deal. His tech is outstanding, his record speaks for itself, he is highly educated...
GREEN FLAGS.
Chairman = David L. Barker PhD:
-Served since 2016.
-Scientific advisor @ MiNDERA Corp and Luna DNA.
-Served on MULTIPLE bio company boards including Amersham (now part of GE).
-Fellow @ Harvard Medical School.
-BS Hons in Chem from CalTech.
COMPETENCE.
-Served since 2016.
-Scientific advisor @ MiNDERA Corp and Luna DNA.
-Served on MULTIPLE bio company boards including Amersham (now part of GE).
-Fellow @ Harvard Medical School.
-BS Hons in Chem from CalTech.
COMPETENCE.
Now onto Saphyr and COVID-19:
March 31st PR:
-A COVID study in Wuhan, China is being carried out by GrandOmics - a service provider using BNGO technology. (Saphyr)
-They're looking at how a COVID patient's DNA affects their resistance or sensitivity to COVID-19.
March 31st PR:
-A COVID study in Wuhan, China is being carried out by GrandOmics - a service provider using BNGO technology. (Saphyr)
-They're looking at how a COVID patient's DNA affects their resistance or sensitivity to COVID-19.
-New study: Hanover, Germany.
-1000 patients & controls. Controls include relatives & partners.
-IN DEPTH STUDY - They're looking at everything from genetic resistance all the way to T-cell response.
-Uses Saphyr.
...
-1000 patients & controls. Controls include relatives & partners.
-IN DEPTH STUDY - They're looking at everything from genetic resistance all the way to T-cell response.
-Uses Saphyr.
...
...
-CEO Erik Holmlin says that BNGO's Saphyr tech is the only tech in the world that can identify the genetic variants which may control the way someone is affected by covid.
VALUE. VALUE. VALUE.
We hear a lot about the need for an understanding of COVID-19. This is how.
-CEO Erik Holmlin says that BNGO's Saphyr tech is the only tech in the world that can identify the genetic variants which may control the way someone is affected by covid.
VALUE. VALUE. VALUE.
We hear a lot about the need for an understanding of COVID-19. This is how.
CANCER:
-Saphyr tech can be used in cancer research too. Looks for structural variations in DNA
-DNA will be compared to that of a control, just like how it is in the COVID trials
-As we advance our knowledge of cancer, this tech will become more and more widespread.
-Saphyr tech can be used in cancer research too. Looks for structural variations in DNA
-DNA will be compared to that of a control, just like how it is in the COVID trials
-As we advance our knowledge of cancer, this tech will become more and more widespread.
July 16th PR:
-First ever lab assembly of a human X-chromosome.
-They used BNGO tech. - Saphyr.
-Stock price rose.
-This company is GROUNDBREAKING.
$BNGO are waging war on all fronts; COVID, Cancer, Chromosome assembly and more.
There is enormous value here.
-First ever lab assembly of a human X-chromosome.
-They used BNGO tech. - Saphyr.
-Stock price rose.
-This company is GROUNDBREAKING.
$BNGO are waging war on all fronts; COVID, Cancer, Chromosome assembly and more.
There is enormous value here.
Financials:
-Need to regain NASDAQ compliance by 28th December 2020.
-Net Loss. (Due partly to global business during the pandemic)
-Cash on hand ~$8million
-Poor assets to liabilities. ($19mil assets compared with $23mil liabilities)
...
-Need to regain NASDAQ compliance by 28th December 2020.
-Net Loss. (Due partly to global business during the pandemic)
-Cash on hand ~$8million
-Poor assets to liabilities. ($19mil assets compared with $23mil liabilities)
...
..
-CEO: "The silver lining for us has been the tremendous work and global effort being put forth toward identifying a testing solution for COVID-19, and Bionano has been committed to supporting these efforts."
CEO = optimistic. Financials may improve as we push out of pandemic
-CEO: "The silver lining for us has been the tremendous work and global effort being put forth toward identifying a testing solution for COVID-19, and Bionano has been committed to supporting these efforts."
CEO = optimistic. Financials may improve as we push out of pandemic
INSTITUTIONAL OWNERSHIP (2.2% of stock):
-Alyeska Investment Group => Chicago based hedge fund.
-Bank Julius Baer & Co. Ltd => Run Hedge Funds in Zurich.
Hedge fund interest. Positive signs.
-Alyeska Investment Group => Chicago based hedge fund.
-Bank Julius Baer & Co. Ltd => Run Hedge Funds in Zurich.
Hedge fund interest. Positive signs.
Risks:
-May see some kind of stock offerings to help reduce debts in future. Seems to be the way of some Pharma companies.
-We don't reach compliance in time.
-May see some kind of stock offerings to help reduce debts in future. Seems to be the way of some Pharma companies.
-We don't reach compliance in time.
Potential Catalysts:
-Covid study results may help boost the image of the company.
-Further covid studies in the future
-PRs bound to drop frequently as company reaches for compliance
-Sales of Saphyr and new product Bionano Prep could help boost stock depending on the order
-Covid study results may help boost the image of the company.
-Further covid studies in the future
-PRs bound to drop frequently as company reaches for compliance
-Sales of Saphyr and new product Bionano Prep could help boost stock depending on the order
CHART:
-Higher lows.
-MA crossover.
-RSI uptick.
-Potential MACD cross.
-Force on the up.
-Volume coming in.
Good entry point <.6
I'm looking for $1.
Medium term play. PRs will be big here.
-Higher lows.
-MA crossover.
-RSI uptick.
-Potential MACD cross.
-Force on the up.
-Volume coming in.
Good entry point <.6
I'm looking for $1.
Medium term play. PRs will be big here.
Conclusion:
-Covid play
-Saphyr = groundbreaking
-Chart = beauty
-We should see regular PR
-Genetics could prove to play a major part in a person's experience of COVID-19, if proven so Saphyr sales will rocket
-Finances sub-par but CEO is optimistic.
-Hedge fund interest.
-Covid play
-Saphyr = groundbreaking
-Chart = beauty
-We should see regular PR
-Genetics could prove to play a major part in a person's experience of COVID-19, if proven so Saphyr sales will rocket
-Finances sub-par but CEO is optimistic.
-Hedge fund interest.
Wow, again thanks for reading. I really like this one and will be looking for a dip to enter on Monday. Remember this isn't advice, just my observations :))
Just a word on our stocks community. I love it! Everyone I'm speaking with is amazing and I enjoy talking with you guys:))
Just a word on our stocks community. I love it! Everyone I'm speaking with is amazing and I enjoy talking with you guys:))
